rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPHARM Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 21 Mar ' 20 Mar ' 19 Mar ' 18 Mar ' 17
Sources of funds
Owner's fund
Equity share capital 23.66 2.37 23.66 23.66 18.66
Share application money - 55.36 - - 4.00
Preference share capital - - - - -
Reserves & surplus 33.11 -6.78 -2.86 16.87 22.32
Loan funds
Secured loans 2.50 3.02 46.23 44.37 80.14
Unsecured loans - - - 2.17 2.24
Total 59.27 53.96 67.02 87.06 127.36
Uses of funds
Fixed assets
Gross block 79.57 74.09 72.87 72.54 72.41
Less : revaluation reserve - - - - -
Less : accumulated depreciation 43.60 39.12 35.85 32.60 29.09
Net block 35.97 34.97 37.02 39.94 43.32
Capital work-in-progress 0.83 0.21 - - -
Investments - - 1.43 1.43 18.33
Net current assets
Current assets, loans & advances 49.67 35.88 82.19 86.15 105.50
Less : current liabilities & provisions 27.19 17.10 53.62 40.45 39.79
Total net current assets 22.47 18.78 28.57 45.70 65.71
Miscellaneous expenses not written - - - - -
Total 59.27 53.96 67.02 87.06 127.36
Notes:
Book value of unquoted investments - - 1.43 1.43 18.33
Market value of quoted investments - - - - -
Contingent liabilities - - - 0.46 0.29
Number of equity sharesoutstanding (Lacs) 236.56 23.66 236.56 236.56 186.56

Mutual Fund Selector

Find the fund that is right for you
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close